benserazide has been researched along with Sleep Apnea Syndromes in 2 studies
Benserazide: An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.
benserazide : A carbohydrazide that results from the formal condensation of the carboxy group of DL-serine with the primary amino group of 4-(hydrazinylmethyl)benzene-1,2,3-triol. An aromatic-L-amino-acid decarboxylase inhibitor (DOPA decarboxylase inhibitor) that does not enter the central nervous system, it is used as its hydrochloride salt as an adjunct to levodopa in the treatment of parkinsonism. By preventing the conversion of levodopa to dopamine in the periphery, it causes an increase in the amount of levodopa reaching the central nervous system and so reduces the required dose. Benserazide has no antiparkinson actions when given alone.
Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Improving sleep quality in patients with obstructive sleep apnea (OSA) by positive airway pressure therapy is associated with a decrease of blood pressure (BP)." | 1.72 | The impact of treatment of periodic limb movements in sleep on blood pressure in patients with and without sleep apnea. ( Babel, N; Bertram, S; Büchner, N; Doevelaar, A; Mühlberger, D; Racovitan, D; Rohn, B; Seibert, FS; Seidel, M; Toma, D; Wang, S; Westhoff, TH, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toma, D | 1 |
| Bertram, S | 1 |
| Racovitan, D | 1 |
| Seidel, M | 1 |
| Doevelaar, A | 1 |
| Seibert, FS | 1 |
| Rohn, B | 1 |
| Babel, N | 1 |
| Mühlberger, D | 1 |
| Büchner, N | 1 |
| Wang, S | 1 |
| Westhoff, TH | 1 |
| Yoshida, T | 1 |
| Kono, I | 1 |
| Yoshikawa, K | 1 |
| Hashimoto, H | 1 |
| Harada, H | 1 |
| Nakagawa, M | 1 |
2 other studies available for benserazide and Sleep Apnea Syndromes
| Article | Year |
|---|---|
The impact of treatment of periodic limb movements in sleep on blood pressure in patients with and without sleep apnea.
Topics: Aged; Benserazide; Blood Pressure; Dopamine Agonists; Humans; Levodopa; Middle Aged; Restless Legs S | 2022 |
Improvement of sleep hypopnea by antiparkinsonian drugs in a patient with Parkinson's disease: a polysomnographic study.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benserazide; Cabergoline; Ergolines; Humans; Levodopa | 2003 |